Human Vaccines & Immunotherapeutics (Jan 2022)

COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa

  • Andrea C. Carcelen,
  • Christine Prosperi,
  • Simon Mutembo,
  • Gershom Chongwe,
  • Francis D. Mwansa,
  • Phillimon Ndubani,
  • Edgar Simulundu,
  • Innocent Chilumba,
  • Gloria Musukwa,
  • Phil Thuma,
  • Kelvin Kapungu,
  • Mutinta Hamahuwa,
  • Irene Mutale,
  • Amy Winter,
  • William J. Moss,
  • Shaun A. Truelove

DOI
https://doi.org/10.1080/21645515.2021.1948784
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 6

Abstract

Read online

With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old challenges present themselves, including cold-chain storage, the logistics of mass vaccination, and vaccine hesitancy. Understanding how much hesitancy toward COVID-19 vaccines might occur and what factors may be driving these concerns can improve the ability of public health workers and communicators to maximize vaccine uptake. We nested a survey within a measles-rubella mass vaccination campaign in Zambia in November 2020 and asked about sentiments and beliefs toward COVID-19 and COVID-19 vaccines. Among parents bringing their children to receive a measles-rubella vaccine, we found high acceptability of COVID-19 vaccination of their children, but substantial uncertainty and hesitancy about receiving the vaccine themselves. COVID-19 vaccination hesitancy was correlated with beliefs around COVID-19 severity and risk, as well as vaccine safety and effectiveness.

Keywords